| | | Deletion (splice acceptor variant +1 more) | Malignant tumor of breast | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Microsatellite (3 prime UTR variant +1 more) | Breast and Ovarian Cancer Susceptibility | |
| | RAD51D, RAD51L3-RFFL (S187fs +2 more) | Indel (frameshift variant +3 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion (stop lost +3 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Microsatellite (3 prime UTR variant +1 more) | Breast and Ovarian Cancer Susceptibility | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Microsatellite (3 prime UTR variant +1 more) | not specified | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T191fs +2 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (stop lost +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (stop lost +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (stop lost +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Single nucleotide variant (stop lost +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (T328I +2 more) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T328A +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (T216S +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q347L +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q327* +2 more) | Single nucleotide variant (nonsense +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (D326A +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (G213fs +2 more) | Deletion (frameshift variant +1 more) | Gastric cancer | |
| | RAD51D, RAD51L3-RFFL (G325V +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (G213D +2 more) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | RAD51D, RAD51L3-RFFL (G213C +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (G325R +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (G325S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (Q324H +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (Q324H +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (Q212L +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q212R +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q212K +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q212* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51L3-RFFL, RAD51D (Q212fs +2 more) | Insertion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (L323* +2 more) | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (L343S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (L323* +2 more) | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (L211* +2 more) | Indel (nonsense +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (L211V +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (T322fs +2 more) | Duplication (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (T342fs +2 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (A209fs +2 more) | Microsatellite (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S208N +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (S208T +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (S320I +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (Q339H +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (Q207H +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | RAD51D, RAD51L3-RFFL (Q319* +2 more) | Single nucleotide variant (nonsense +1 more) | not specified +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (E338G +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (E318K +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (S337L +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (T204fs +2 more) | Duplication (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (T204fs +2 more) | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (G315V +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (G315E +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (G315R +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (W202C +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51L3-RFFL, RAD51D (W314S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (W202* +2 more) | Single nucleotide variant (nonsense +1 more) | Gastric cancer | |
| | RAD51D, RAD51L3-RFFL (W314R +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (T333I +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T201S +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T201N +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (G200E +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (G312A +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (G200V +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (G200R +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (G200W +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (I311M +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Deletion (inframe_deletion +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (I311T +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51L3-RFFL, RAD51D (I311N +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +6 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (I199F +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (I311L +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |